Psychodynamic therapies versus treatment as usual for depression

Theresa Hm Moore; Vivien Hunot; Philippa Davies; Deborah Caldwell; Hannah Jones; Glyn Lewis; Rachel Churchill

doi:10.1002/14651858.CD008707

Psychodynamic therapies versus treatment as usual for depression

Cochrane Database Syst Rev. 2010:(9):CD008707. doi: 10.1002/14651858.CD008707.

Authors

Theresa Hm Moore¹, Vivien Hunot¹, Philippa Davies¹, Deborah Caldwell², Hannah Jones³, Glyn Lewis², Rachel Churchill¹

Affiliations

¹ Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK.
² School of Social and Community Medicine, University of Bristol, Bristol, UK.
³ Cochrane Schizophrenia Group, The University of Nottingham, Nottingham, UK.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To examine the effectiveness and acceptability of all psychodynamic therapies compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of different psychodynamic therapy models (drive/structural, relational and integrative analytic models) compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.To examine the effectiveness and acceptability of all psychodynamic therapies compared with different types of comparator (standard care, no treatment, waiting list, attention placebo) for acute depression.